°í°´¼¾ÅÍ

Á¶È¸¼ö 6540
Á¦¸ñ pycnogenol°úsaponinÀÌ ÇǺÎâ»óÄ¡À¯¿¡¹ÌÄ¡´ÂÈ¿°ú
µî·ÏÀÏ 2013-09-05

È­¸é ÇÏ´Ü¿¡ ÷ºÎÆÄÀÏÀ» Ŭ¸¯ ÇϽøé

¿øº»ÆÄÀÏ (PDFÆÄÀÏ)·Î Á»´õ Æí¾ÈÇÏ°Ô º¸½Ç ¼ö ÀÖ½À´Ï´Ù.

 

============================================================================================

 

 

 

ÀúÀÛÀÚÇ¥½Ã-ºñ¿µ¸®-º¯°æ±ÝÁö 2.0 ´ëÇѹα¹

ÀÌ¿ëÀÚ´Â ¾Æ·¡ÀÇ Á¶°ÇÀ» µû¸£´Â °æ¿ì¿¡ ÇÑÇÏ¿© ÀÚÀ¯·Ó°Ô

l ÀÌ ÀúÀÛ¹°À» º¹Á¦, ¹èÆ÷, Àü¼Û, Àü½Ã, °ø¿¬ ¹× ¹æ¼ÛÇÒ ¼ö ÀÖ½À´Ï´Ù.

´ÙÀ½°ú °°Àº Á¶°ÇÀ» µû¶ó¾ß ÇÕ´Ï´Ù:

l ±ÍÇÏ´Â, ÀÌ ÀúÀÛ¹°ÀÇ ÀçÀÌ¿ëÀ̳ª ¹èÆ÷ÀÇ °æ¿ì, ÀÌ ÀúÀÛ¹°¿¡ Àû¿ëµÈ ÀÌ¿ëÇã¶ôÁ¶°Ç

À» ¸íÈ®ÇÏ°Ô ³ªÅ¸³»¾î¾ß ÇÕ´Ï´Ù.

l ÀúÀÛ±ÇÀڷκÎÅÍ º°µµÀÇ Çã°¡¸¦ ¹ÞÀ¸¸é ÀÌ·¯ÇÑ Á¶°ÇµéÀº Àû¿ëµÇÁö ¾Ê½À´Ï´Ù.

ÀúÀ۱ǹý¿¡ µû¸¥ ÀÌ¿ëÀÚÀÇ ±Ç¸®´Â À§ÀÇ ³»¿ë¿¡ ÀÇÇÏ¿© ¿µÇâÀ» ¹ÞÁö ¾Ê½À´Ï´Ù.

ÀÌ°ÍÀº ÀÌ¿ëÇã¶ô±Ô¾à(Legal Code)À» ÀÌÇØÇϱ⠽±°Ô ¿ä¾àÇÑ °ÍÀÔ´Ï´Ù.

Disclaimer

ÀúÀÛÀÚÇ¥½Ã. ±ÍÇÏ´Â ¿øÀúÀÛÀÚ¸¦ Ç¥½ÃÇÏ¿©¾ß ÇÕ´Ï´Ù.

ºñ¿µ¸®. ±ÍÇÏ´Â ÀÌ ÀúÀÛ¹°À» ¿µ¸® ¸ñÀûÀ¸·Î ÀÌ¿ëÇÒ ¼ö ¾ø½À´Ï´Ù.

º¯°æ±ÝÁö. ±ÍÇÏ´Â ÀÌ ÀúÀÛ¹°À» °³ÀÛ, º¯Çü ¶Ç´Â °¡°øÇÒ ¼ö ¾ø½À´Ï´Ù.

Doctoral Dissertation

Effects of Pycnogenol and Saponin

on Skin Wound Healing

Department of Veterinary Medicine

Graduate School, Chonnam National University

KIM, Youngsoo

August 2012

Effects of Pycnogenol and Saponin

on Skin Wound Healing

Department of Veterinary Medicine

Graduate School, Chonnam National University

KIM, Youngsoo

DirectedbyProfessorBAE,Chunsik

A dissertation submitted in partial fulfillment of the requirements

for the Doctor of Philosophy in Veterinary Medicine.

CommitteeinCharge:

KANG,Seongsoo

JEONG,Moonjin

CHO,Ikhyun

KIM,Sungho

BAE,Chunsik

August 2012

- i -

CONTENTS

List of Figures ...................................................................................... ¥¢

ABSTRACT ............................................................................................ 1

INTRODUCTION .................................................................................... 4

MATERIALS AND METHODS .............................................................. 8

1. Animals ........................................................................................... 8

2. Animal model of incised skin wound .......................................... 8

3. Pycnogenol (PYC) ......................................................................... 9

4. Total ginseng saponin (TGS) ....................................................... 9

5. Histological analysis ..................................................................... 9

6. Statistical analysis ........................................................................ 10

RESULTS ............................................................................................... 11

1. Effects of Pycnogenol on Skin Wound Healing ............................ 11

1.1. Wound healing tendencies after pycnogenol treatment ........... 11

1.2. Histological and morphometric analysis of the skin wound

healing following pycnogenol treatment .................................... 13

1.3. Histological analysis of inflammatory cells and wound

contraction rate during the skin wound healing process ....... 17

1.4. Substrate formation analysis in the wound healing process

........................................................................................................ 21

2. Effects of Saponin on Skin Wound Healing ................................... 24

2.1. Wound healing tendencies after saponin treatment .................. 24

2.2. Histological and morphometric analysis of the skin wound

healing following saponin treatment .......................................... 26

2.3. Histological analysis of inflammatory cells and wound

contraction rate during the skin wound healing process ....... 30

2.4. Substrate formation analysis in the wound healing process

........................................................................................................ 34

DISCUSSION .......................................................................................... 37

CONCLUSION ........................................................................................ 46

REFERENCES ........................................................................................ 47

ABSTRACT (KOREAN) ......................................................................... 54

- ii -

List of Figures

Figure 1. Chemical structures of the main procyanidins present in the

pycnogenol extract and their possible oligomeric assembly ...... 5

Figure 2. Chemical structure of Saponin extracted from Panax

Ginseng ................................................................................... 6

Figure 3. Differences of dermal wound size between control and

pycnogenol-treated groups ................................................... 12

Figure 4. Differences in wound area between control and

pycnogenol-treated groups during skin wound healing ..... 14

Figure 5. Differences in wound area between control and

pycnogenol-treated group ..................................................... 15

Figure 6. Keratinocyte migration in wound tissue .............................. 16

Figure 7. Differences in inflammatory cell recruitment between

control and pycnogenol-treated skin wounds .................... 18

Figure 8. Inflammatory cells count analysis of wound tissues ......... 19

Figure 9. Wound contraction measurements between control and

pycnogenol-treated groups ................................................... 20

Figure 10. Difference of accumulated collagen in healing areas

between control and pycnogenol-treated groups .............. 22

Figure 11. Difference in accumulated collagen in the healing areas

of control and pycnogenol-treated groups ......................... 23

Figure 12. Differences of dermal wound size between control and

saponin-treated groups ......................................................... 25

Figure 13. Differences in wound area between control and saponintreated

groups during skin wound healing ......................... 27

Figure 14. Differences in wound area between control and

saponin-treated group ........................................................... 28

Figure 15. Keratinocyte migration in wound tissue .............................. 29

Figure 16. Difference in inflammatory cell recruitment between

control and saponin-treated skin wounds ........................... 31

Figure 17. Inflammatory cells count analysis of wound tissues ......... 32

Figure 18. Wound contraction measurements between control and

saponin-treated groups ....................................................... 33

Figure 19. Difference of accumulated collagen in healing areas

between control and saponin-treated groups ..................... 35

Figure 20. Difference in accumulated collagen in the healing areas

of control and saponin-treated groups ............................... 36

- 1 -

Effects of Pycnogenol and Saponin

on Skin Wound Healing

KIM, Youngsoo

Department of Veterinary Medicine

Graduate School, Chonnam National University

(Supervised by Professor BAE, Chunsik)

(Abstract)

Cutaneous wound healing involves various cell types for the renewal

of damaged tissues, where strict regulation of soluble and insoluble

factors is required. The medical agents and antibiotics currently used

for wound healing have side effects, such as allergy and potential

infection by super bacteria. Therefore, much effort has been focused

on the investigation of natural plant extracts to replace artificial

chemicals for the application in wound healing. Pycnogenol is a

water-soluble extract of French maritime pine bark that consists of

several types of phenolic compounds and is known to have

antioxidants and anti-inflammatory effects. Also, saponins have been

reported to confer strong anti-inflammatory effects, leading to a

decrease in neutrophilic infiltration.

The purpose of this study was to investigate the effects of

- 2 -

pycnogenol and saponin on the cutaneous wound healing process via

histological analysis. A 48 heads of ICR mice, 6 weeks old were used

for all in vivo experiments. These mice were divided a control,

pycnogenol-, or saponin-treated groups after inducing four equidistant

1 cm full-thickness incisional wounds on the dorsum. The wound site

samples were extracted on days 1, 3, 5, and 7 after induction of

wounding and histomorphometrical analysis was performed, such as

measurement of the wound area, the keratinocyte migration rate,

calculation of infiltrated inflammatory cells, and measurement of wound

contracture.

As a result, the wound areas of the pycnogenol-treated group were

larger than the control group on days 1 to 7, and the keratinocyte

migration rates of the pycnogenol-treated group were lower than the

control group on days 3 to 7. The number of inflammatory cells of the

pycnogenol-treated group was higher than the control group on days 3

to 7. The wound contraction of the pycnogenol-treated group was

lower than the control group on days 1 to 5 but higher on day 7.

Collagen deposition in the pycnogenol-treated group was less than in

the control group but greater than the control group on day 7.

The wound areas of the saponin-treated group were smaller than the

control group on days 3 to 7, and the keratinocyte migration rates of

the saponin-treated group were higher than the control group at day 3

to day 7. The number of inflammatory cells from the saponin-treated

group on day 1 and 3 was lower than the control group. The wound

contraction of the saponin-treated group was higher than the control

group on days 3 to 5. Collagen deposition in the saponin-treated group

- 3 -

was greater in the control group during wound healing.

According to our results, it appears that pycnogenol does not

promote re-epithelialization of the wound site but inhibits the initial

inflammatory response and promotes the substrate synthesis of the

second half of the skin wound recovery process. Also, saponin

promotes re-epithelialization of the wound site and effectively inhibits

the initial inflammatory response and promotes substrate synthesis.

Altogether, we conclude that saponin shows higher efficacy during

the wound recovery process after skin incision.

- 4 -

INTRODUCTION

The recovery process of skin wounds involves complex biological

mechanisms but can be essentially classified into three phases: 1)

inflammatory, 2) granulation formation as the result of cell

proliferation, and 3) tissue remodeling (Stephen and Thomas, 2002).

Many cell types and their interactions are responsible for these

process, including inflammatory cells, fibroblasts, and keratinocytes

which induce microenvironmental changes at the wound site (Wrener et

al., 2007). Tissue remodeling of the dermis involves collagen as well

as antioxidants and a balance of matrix-producing proteins and

protease enzymes essential for the initiation of tissue remodeling

during the recovery process of skin wounds (Blazso et al., 2004).

Pycnogenol (PYC), an aqueous extract of the bark of P. pinaster

(formerly known as P. maritima), is primarily composed of procyanidins

and phenolicacids. Procyanidins are biopolymers of catechin and

epicatechin subunits, which are recognized as important constituents in

human nutrition (Packer et al., 1999) (Fig. 1). PYC contains a wide variety

of procyanidins that range from the monomeric catechin and taxifolin

to oligomers with 7 or more flavonoid subunits. The phenolic acids are

derivatives of benzoic and cinnamic acids (Rohdewald, 2002). PYC

protects against oxidative stress in several cell systems by doubling

the intracellular synthesis of anti-oxidative enzymes and by acting as a

potent scavenger of free radicals (Berryman et al., 2004). Pycnogenol

has multiple biological effects, including antioxidant, anti-inflammatory

and anti-carcinogenic properties (Sime et al., 2004).

- 5 -

Fig. 1. Chemical structures of the main procyanidins present in the

pycnogenol extract (top) and their possible oligomeric assembly (bottom).

Protection against UV-radiation-induced erythema was found in a

clinical study following oral administration of PYC (Blazsóet al., 1997).

PYC can inhibit the expression of the proinflammatory cytokine

interleukin (IL)-1¥â by regulating redox-sensitive transcription factors

(Cho et al., 2000), leading to significantly curtailing the wound healing

time when applied topically to experimental wounds inflicted by

branding iron to healthy rats (Blazsóet al., 2004).

- 6 -

Fig. 2. Chemical structure of Saponin extracted from Panax Ginseng

Saponins are compounds extensively found in most plants that exist

in a variety of types and are classified based on their internal

structure (Guclu-Ustundag and Mazza, 2007) (Fig. 2). Saponins have

been reported to accelerate numerous biological activities including

hemolytic (Baumann et al., 2000; Oda et al., 2000), anti-bacterial

(Killeen et al., 1998; Konishi et al., 1998), anti-viral (Simoes et al.,

1999; Apers et al., 2001), and anti-oxidative functions (Yogeeswari and

Sriram, 2005). In addition, saponins were also observed to have

anti-inflammatory effects, reducing edema and skin inflammation (Just

et al., 1998; Navarro et al., 2001). A saponin extracted from ginseng,

known as ginsenoside, has been shown to accelerate neovascularization

in burn wounds of the skin in mice and to increase vascular

endothelial growth factor and IL-1¥â, inflammatory cytokines known to

induce the accumulation of macrophages at skin wound sites and

accelerate wound healing (Kimura et al., 2006).

- 7 -

However, the recovery pattern of skin wounds caused by burns varies

markedly from that caused by physical injury or surgery (Wang et al.,

2008). Pycnogenol and saponin have been shown to be effective in the

wound healing process; however, information on surgical skin wounds

is little to lacking. Thus, this study was aimed at investigating the

effects of pycnogenol and saponin during the healing process at

surgically induced skin wounds using histochemical and

histomorphometric analysis.

- 8 -

MATERIALS AND METHODS

1. Animals

Male ICR mice (n=48) weighing 45 to 55 g were purchased from

Samtako (Osan, Korea). The mice were quarantined and acclimated for

one week prior to use. The animals were housed in polycarbonate

cages in a room maintained at 23¡¾2¡ÆC, a relative humidity of 50¡¾5%,

artificial lighting from 08:00 to 20:00 h, and 13 to 18 air changes per

hour. Tap water and commercial rodent chow (Samyang Feed, Daejeon,

Korea) were provided ad libitum. The animals were blindly randomized

into control (n=24), pycnogenol (PYC, n=12) and total ginseng saponin

(TGS, n=12) groups.

2. Animal model of incised skin wound

The animal model with an incised skin wound has been established

and described previously (Guan et al., 2000). Briefly, 6-week-old male

ICR mice were anesthetized by intraperitoneal injection of xylazine

(Rompun¢ç, 2 mg/kg; Bayerkorea, Seoul, Korea) and zolazepam/

tiletamine (Zoletil 50¢ç, 0.1 mg/kg; Virbac, Seoul, Korea). A scalpel was

used to generate four 1-cm-long incisions on the central dorsum skin

layer. Specimens (1.5¡¿2 cm2) were taken from the wound sites while

anesthetized on days 1, 3, 5, and 7 post-wounding (n=3/group).

Experiments conformed to the ¡®Principles of Laboratory Animal Care

(National Institutes of Health publication no. 85-23, revised 1985)¡¯ and

sought to minimize both the number of animals used and any suffering

that might be experienced and were performed according to the

- 9 -

Guidelines for the Care and Use of Laboratory Animals of Chonnam

National University.

3. Pycnogenol (PYC)

Pycnogenol was provided by the Horphag Research Ltd., France. The

PYC (1 mg/50 ¥ìL/wound) was dissolved in saline and administered once

subcutaneously prior to making the surgical skin wound in the treated

group.

4. Total ginseng saponin (TGS)

TGS was provided by the Korean Ginseng Research Institute, Korea

Ginseng Corporation (KGC, Daejeon, Korea). The provided TGS

contained 11 glycosides known as ginsenosides: Rb1 (15.82%), Rb2

(7.79%), Rc (8.06%), Rd (7.57%), Re (3.21%), Rf (4.72%), Rg1 (1.91%),

Rg2 (22.08%), Rg3 (24.06%), Rh1 (4.63%), and Rh2 (0.15%). The TGS

(1 mg/50 ¥ìL/wound) was dissolved in saline and administered once

subcutaneously prior to making the surgical skin wound in the treated

group.

5. Histological analysis

To compare changes between the groups, mice were euthanized on

days 1, 3, 5, and 7 post-wounding. Pictures of the wounds were taken

with a digital camera (DMCFZ5GD; Panasonic, Kadoma, Japan) after

attaching a ruler to the skin wound area. Skin samples from the wound

area were taken and kept in 4% formaldehyde in phosphate-buffered

saline (PBS, pH 7.4) for 24 h, then washed with PBS for 2 h,

- 10 -

dehydrated using graded alcohol, clarified, and finally embedded into

paraffin. The embedded samples were cut into 6-¥ìm-thick sections

with a motorized rotary microtome MT990 (RMC Products, Tucson, AZ,

USA). Hematoxylin and eosin (H&E) staining was performed to

measure the size of the wound area and detect any histomorphometric

changes. To analyze the number of inflammatory cells, Giemsa staining

was performed. To analyze the collagen in the matrix formation,

Masson¡¯s trichrome and picrosirius red staining were used. In the

wound area, measurements were made at the epithelium as well as the

marginal area of the connective tissue. The number of inflammatory

cells was counted at the left, right, and center of the wound area. The

keratinocyte migration rate was determined by measuring the size of

the epithelial tissue rising from the edge of the wound, while the

wound contraction was calculated by measuring the distance between

the edge of the wound and the damaged dermal layer. Stained tissue

samples were observed using a polarizing microscope (Carl Zeiss,

Goettingen, German), and the AxioVisionLE release 4.6 (Carl Zeiss)

image analysis program was used for all analyses.

6. Statistical analysis

Data presented are mean values from three animal ¡¾ SD. Statistical

analysis of the data was performed using a Student¡¯ t-test with a

Bonferroni correction for analysis of multiple comparisons. Differences

were considered significant at p<0.05.

- 11 -

RESULTS

1. Effects of Pycnogenol on Skin Wound Healing

1.1. Wound healing tendencies after pycnogenol treatment

To determine the effect of pycnogenol on wound healing, changes in

the wound size were recorded on days 1, 3, 5, and 7 after wound

induction. It was evident that healing was taking place over time

because wounds were being reduced in both the control and the

pycnogenol-treated groups.

In the pycnogenol-treated group, there were no significant changes

in the wound size compared to the control group until day 5. On day

7, the wound size of the control group appeared to reduce more in

size (Fig. 3).

- 12 -

Fig. 3. Differences in the dermal wound size between the control and

the pycnogenol-treated groups. The wound size gradually diminished in

both groups from days 1 to 7. However, there were no differences

between the two groups until day 7.

- 13 -

1.2. Histological and morphometric analysis of the skin wound healing

following pycnogenol treatment

H&E staining was conducted for wound tissues extracted in each

period after inducing skin wounds. Most wound tissues of the control

group appeared to be collapsed and lost on day 1, and scabs caused

by blood clots and fibrous tissues were observed. Removal of scabs

gradually progressed until day 5, and the movement of epithelial cells

was confirmed at this time and most dermal residues disappeared. On

day 7, scabs were completely eliminated, and the wound part was

completely blocked with the outside skin due to re-epithelialization.

Also, the wound site including the derma was markedly reduced

compared to day 1. The pycnogenol-treated group showed a pattern

similar to the control group until day 3 after the wound induction, but

scabs were not removed until day 5 and movement of epithelial cells

was also observed to be lower than that of the control group (Fig. 4).

The wound measurements showed that the wound area of the control

group increased slightly on day 3 compared to day 1, albeit not in a

significant manner, and it decreased on day 5. On day 7, the wound

area decreased significantly. In the pycnogenol-treated group, the

wound size decreased from days 1 to 7, but the reduction in size

decreased on day 7 (Fig. 5).

In regards to the keratinocyte migration rate, both the control and

the pycnogenol-treated groups demonstrated an increasing tendency.

On day 1, however, both the control and the pycnogenol-treated

groups were similar but the pycnogenol-treated group showed lower

values than those of the control group at all other times (Fig. 6).

- 14 -

Fig. 4. Differences in the wound area between the control and the

pycnogenol-treated groups during skin wound healing. There were no

differences between the groups until day 3. However, scar tissues

were observed in the pycnogenol-treated group on day 5. Scale

bar=200 ¥ìm

- 15 -

Fig. 5. The wound area of the pycnogenol-treated group was larger

than the control group on days 1 to 7, based upon morphometric

analysis of the wounds tissues from the control and the pycnogenoltreated

groups.

- 16 -

Fig. 6. Keratinocyte migration in the wound tissue. The keratinocyte

migration rate in the pycnogenol-treated group was lower than that of

the control group on days 3 to 7.

- 17 -

1.3. Histological analysis of inflammatory cells and wound contraction

rate during the skin wound healing process

To compare the number of inflammatory cells introduced in the

wound site, tissues that caused wounds were subjected to Giemsa

staining (Fig. 7), which showed the highest number of inflammatory

cells in the control group on day 1. But after day 3, up to day 7, the

number declined sharply.

It could be observed that in the pycnogenol-treated group, there

were less inflammatory cells than in the control group only on day 1,

but it maintained more inflammatory cells than those of the control

group from days 3 to 5, and the number increased on day 7 (Fig. 8).

Also, both the control and the pycnogenol-treated groups showed an

increasing tendency in the analysis of wound contraction. The degree

of contraction in the pycnogenol-treated group was lower than that of

the control group from days 1 to 5 but appeared higher on day 7 (Fig.

9).

- 18 -

Fig. 7. Differences in the recruitment of inflammatory cells between

the control and the pycnogenol-treated skin wounds. Inflammatory cells

in the pycnogenol-treated wounds were increased from days 3 to 7,

compared to the control wound tissue. All tissues were subjected to

Giemsa staining. Scale bar=20 ¥ìm

- 19 -

Fig. 8. The inflammatory cell count of the wound tissues. Inflammatory

cells were counted in three distinctive areas (left, right, and middle of

the wound area). The number of inflammatory cells in the

pycnogenol-treated group was lower than the control group on day 1.

However, from days 3 to 5, the number of inflammatory cells of the

pycnogenol-treated group was higher than the control, and on day 7

inflammatory cells of the pycnogenol-treated group were more

increased than the control group.

- 20 -

Fig. 9. Wound contraction in the pycnogenol-treated group was lower

than that of the control group on days 1 to 5. However, wound

contraction in the pycnogenol-treated group was higher than in the

control group on day 7.

- 21 -

1.4. Substrate formation analysis in the wound healing process

To identify how long the reformation of the derma takes during skin

wound recovery, Masson's trichrom staining and picrosirius red staining

were conducted, and then the collagen deposit time was observed. In

the control group, collagen synthesis, stained as light blue, was

identified around the wound from around day 3 after inducing wounds.

In the control and the pycnogenol-treated groups, dark blue staining

was observed in the tissues on days 5 and 7 (Fig. 10).

Quantitative collagen deposit analysis showed clear collagen

synthesis from day 5 and increased on day 7. Compared to the control

group, collagen accumulation in the pycnogenol-treated group was

higher than that of the control group from days 5 to 7 (Fig. 11).

- 22 -

Fig. 10. Difference in collagen accumulation (blue color) in the healing

areas between the control and the pycnogenol-treated groups. Collagen

in the healing area of the control and the pycnogenol-treated groups

gradually increased from days 1 to 7. Collagen deposition in the

pycnogenol-treated group was greater than in the control group on

days 5 and 7. Scale bar=100 ¥ìm

- 23 -

Fig. 11. Difference in the accumulated collagen (bright red color) in

the healing areas of the control and the pycnogenol-treated groups.

This result was consistent with the collagen staining. Scale bar=100

¥ìm

- 24 -

2. Effects of Saponin on Skin Wound Healing

2.1. Wound healing tendencies after saponin treatment

To examine the effect of saponin on the wound healing, changes in

the wound size on days 1, 3, 5, and 7 post-wounding were observed

and compared between the control and the saponin-treated groups.

The wound size on day 5 in the saponin-treated group was much

smaller compared to the control group. By day 7, both sides of the

incision were completely joined in the saponin-treated group (Fig. 12).

- 25 -

Fig. 12. Differences in the dermal wound size between the control and

the saponin-treated groups. The wound size gradually reduced in both

groups from days 1 to 7. In the saponin-treated group, the wound size

was more reduced on days 5 and 7 compared to the control group.

- 26 -

2.2. Histological and morphometric analysis of the skin wound healing

following saponin treatment

H&E staining was performed on the wound tissue samples at various

time points post-wounding. Most wound tissues appeared to have

disintegrated in both the control and the saponin-treated groups, and

scabs were observed. However, the amount of scab was smaller,

epithelial cell migration was faster, and less residue in the dermal

layer was present in the saponin-treated group than in the control

group. On day 5 post-wounding, epithelial cell migration was complete

in the saponin-treated group, but not in the control group. The amount

of scab was also less in the saponin-treated group than in the control

group. In addition, the amount of residue in the dermal layer in the

saponin-treated group was much less compared to that of the control

group. By day 7, all scabs had lifted off in both groups. Epithelial cell

migration was fully complete in the saponin-treated group, but the

wound contraction rate appeared to be higher (Fig. 13).

The wound size showed a decreasing trend with time in both groups;

however, by period, the wound sizes in the saponin-treated group

were smaller than those of the control group during the wound healing

process from days 3 to 7 (Fig. 14).

Furthermore, while the keratinocyte migration rate was similar on

day 1 and tended to increase in both groups as time passed, the rate

in the saponin-treated group was higher than that of the control group

(Fig. 15).

- 27 -

Fig. 13. Differences in the wound area between the control and the

saponin-treated groups during skin wound healing. The wound area of

the saponin-treated group was larger than the control group on day 1

but smaller on days 3 to 7. Scale bar=200 ¥ìm

- 28 -

Fig. 14. The wound area of the saponin-treated group was larger than

the control group on day 1 but smaller on days 3 to 7. This result

was based upon the morphometric analysis of the wound tissues from

the control and the saponin-treated groups. * p<0.05

- 29 -

Fig. 15. Keratinocyte migration in the wound tissue. The keratinocyte

migration rate in the saponin-treated group was higher than that of the

control group on days 3 to 7. * p<0.05

- 30 -

2.3. Histological analysis of inflammatory cells and wound contraction

rate during the skin wound healing process

Giemsa staining was performed to analyze the number of

inflammatory cells in the wound area at different time periods. The

largest cell numbers were seen on day 1 post-wounding and gradually

decreased over time. The number of inflammatory cells in the

saponin-treated group was noticeably smaller on days 1 and 3 compared

to the control group and tended to dwindle over time (Fig. 16).

However, the number of inflammatory cells in the saponin-treated group

increased starting on day 5 and was maintained until day 7 (Fig. 17).

The control group showed an increase in the rate of wound

contraction on day 7 after being at a constant level from days 1 to 5,

while the saponin-treated group showed a gradual increase in the rate

of wound contraction reaching the maximum level on day 7. Specifically,

the wound contraction rate of the saponin-treated group was lower

than the control group on day 1 but began to increase from day 3

similar to the control group, eventually becoming higher than the

control group on days 5 to 7 (Fig. 18).

- 31 -

Fig. 16. Difference in the recruitment of inflammatory cells between

the control and the saponin-treated skin wounds. Inflammatory cells in

the saponin-treated wounds were reduced from days 1 to 5 compared

to the control wound tissue but increased on day 7. Scale bar =20 ¥ìm

- 32 -

Fig. 17. Inflammatory cells were counted in three distinctive areas

(left, right, and middle of wound area). Inflammatory cells of the

saponin-treated group were lower than the control group on days 1

and 3. However, the number of inflammatory cells of the saponintreated

group on day 5 was higher than on day 3. On day 7, the

number of inflammatory cells of the saponin-treated group was higher

than the control group. * p<0.05

- 33 -

Fig. 18. Wound contraction measurements between the control and the

saponin-treated groups. Wound contraction in the saponin-treated

group was higher than that of the control group from days 3 to 7.

- 34 -

2.4. Substrate formation analysis in the wound healing process

To confirm the substrate formation in the dermis, Masson's trichrome

and picrosirius red staining were conducted, and then the collagen

deposit time was observed. In the control group, collagen synthesis,

stained as light blue, was identified around the wound area from day

3, and tended to be active in the tissues on days 5 and 7 (Fig. 19).

To confirm collagen disposition, collagen synthesis was first observed

on day 5 and appeared to be increased on day 7. However, collagen

synthesis was deeper in the saponin-treated group than the control

group for the entire study period (Fig. 20).

- 35 -

Fig. 19. Difference in collagen accumulation (blue color) in the healing

areas between the control and the saponin-treated groups. Collagen in

the healing area of the control and the saponin-treated groups

gradually increased from days 1 to 7. Collagen deposition in the

saponin-treated group was greater than in the control group. Scale

bar=100 ¥ìm

- 36 -

Fig. 20. Difference in the accumulated collagen (bright red color) in

the healing areas of the control and the saponin-treated groups. This

result was consistent with the collagen staining. Scale bar=100 ¥ìm

- 37 -

DISCUSSION

In mammals, wound healing involves a prompt and efficient process

in which bleeding from the wound is first terminated, followed by

reformation of the damaged tissues. Then, moisture is evaporated

around the wound, and a functional defense membrane is generated to

protect against invasion by microorganisms. Skin wound healing can be

classified into three phases, which include the initial inflammatory

reaction, re-epithelialization and granulation tissue formation, and

finally tissue remodeling (Clark, 1995). These classifications are based

on histological results or functional activities, but in fact, they overlap.

For ideal healing to occur, interactions between cells and tissues that

are deeply involved in these three phases are essential (Toriseva and

Kahari, 2009).

Blood coagulation is initiated by the formation of clots that form in

combination with fibrin fiber bundles activated by blood coagulation

factors and platelets. Fibronectin and vitronectin in the blood plasma

are included in the blood coagulation phase and temporarily form the

substrate for cell migration. Keratinocytes migrate into this substrate

in which scab formation occurs around the wound with the help of

proteinases. The hemotactic stimulus is provided by growth factors and

platelets secreted by the activated blood coagulation factors,

complement components, and damaged cells (Singer and Clark, 1999).

During the blood coagulation process, neutrophils arrive first at the

damaged tissue within a few hours. Major functions of neutrophils

include phagocytosis, which eliminates the infective agents at the site

- 38 -

of damaged tissue, and the stimulation of blood coagulation,

inflammation, and the healing process by secreting various factors

(Eming et al., 2007). Next, monocytes arrive at the wound within two

days and differentiate into macrophage. They also function as

phagocytes and antigen presenting cells, secreting transforming growth

factors- and, basic fibroblast growth factor, and platelet-derived

growth factor (PDGF) to regulate the wound healing process (Eming et

al., 2007).

Re-epithelialization and granulation tissue formation occur

simultaneously within a few hours of the inflammatory reaction.

Keratinocytes that exist around the edges of the wound and in the

residues of skin appendages begin to migrate into the wound and form

a scab (Singer and Clark, 1999). These keratinocytes are

characteristically hyper-proliferative, which enables them to fill the

damaged epithelial layer and reform the basement membrane within

two days after wound initiation, thereby restoring contact between

cells. Through this process, keratinocytes differentiate to form the

epidermal skin layer (Singer and Clark, 1999). Almost simultaneously,

as fibroblasts located around the undamaged dermis begin to

proliferate and migrate upon stimulation by growth factors, granulation

tissue formation is initiated (Singer and Clark, 1999). Fibroblasts that

migrate into the wound and proliferate synthesize proteoglycans,

collagen type III, and collagen type I to reform the extracellular matrix

around the wound (Clark, 1995). Some fibroblasts differentiate into

myofibroblasts and synthesize smooth muscle actin, which provides

mechanical tension to pull the edges of the wound to stimulate

- 39 -

contraction and eventually promote wound closure (Hinz et al., 2001).

New blood vessels appear in the granulation tissue upon migration and

proliferation of the endothelial cells, which is stimulated by

macrophages or keratinocytes and growth factors secreted from

endothelial cells (Singer and Clark, 1999). The dermis remodeling

phase of skin wound healing involves the full growth of the wound

accompanied by collagenous scarring. This phase is characterized by a

reduction in the number of fibroblasts by apoptosis and removal of

damaged blood vessels. The residual fibroblasts rearrange the collagen

fiber to recover the original tension of the skin, repeating collagen

deposition and degradation for several months. However, the original

skin tension before the damage can never be fully recovered (Singer

and Clark, 1999; Hinz, 2007).

There are various medications available to assist in the skin wound

healing, ranging from disinfectants such as ethyl alcohol, iodine, and

ether, to ointments containing various antibiotics and steroid hormones.

This can lead to injury of not only the invading cells but also normal

cells, as well as induce the emergence of resistant bacteria and cause

various hypersensitivity reactions (Kang, 2004). From the ancient

times, various natural substances have been widely used for wound

healing, anti-aging, and the treatment of other diseases (Hsu, 2005).

Among such extracts, polyphenol compounds are known to be strong

antioxidants capable of neutralizing free radicals by combining with

active oxygen (Hsu, 2005). A hydroxyl group attaches to an aromatic

ring of a polyphenol compound that combines with free radicals, which

appear during the metabolic process and form neutralized stable

- 40 -

phenoxyl radicals (Rice-Evans et al., 1996). Free radicals that reacts

with polyphenol compounds include superoxide radical anions, hydroxyl

radicals, lipid peroxyl radicals, nitric oxide radicals, and peroxynitrites.

All of these have been known to play a significant role not only in the

biological environment but also in the treatment of diseases (Packer et

al., 1999).

Radicals produced by wounds are largely superoxide radical anions

produced by neutrophils and macrophages and also play an important

role in the removal of microorganisms and pathogens (Babior, 2000).

Superoxide radical anions are quickly transformed into hydrogen

peroxide (H2O2) which permeates into the cell membranes of pathogens

by superoxide dismutase, promoting the formation of hypochlorous

acid, chloramines, and aldehyde which are more stable than H2O2, and

are characterized by long half-lives. Thus, when H2O2 substances

remain in the wound for an extended period of time, acute

inflammatory reactions may occur that may potentially damage even

normal cells (Sen et al., 2002).

Pycnogenol, which is one of the polyphenol compounds, is a pine

bark extract and has been used as a medicine for wound recovery and

inflammatory diseases since the ancient times (Packer et al., 1999).

Through basic research and clinical studies, pycnogenol was known not

only to be a powerful antioxidant (Chida et al., 1999; Devaraj et al.,

2002) but as an agent to improve vascular integrity and endothelial

function and to stimulate anti-inflammatory responses (Grimm et al.,

2006). Also, pycnogenol regulates nitric oxide production of activated

macrophages and inhibits iNOS activity and inducible macrophage-type

- 41 -

nitric oxide synthase (iNOS) mRNA expression (Virgili et al., 1998).

Based on the abundant evidence, this study aimed to identify the effect

of pycnogenol on wound recovery inducing skin incisions on the dermal

layer by histological analysis.

Observing the speed of wound recovery with the naked eye showed

no difference between the control group and the pycnogenol-treated

groups. Also, the wound measurement was wider than that of the

control group from days 1 to 7 after inducing wounds. The rates of

keratinocyte migration were similar in both groups on day 1 but lower

in the pycnogenol-treated group than the control group thereafter. This

shows that treatment with pycnogenol has no effect on the speed of

wound recovery, which is not consistent with previous reports.

Pycnogenol was demonstrated to promote wound recovery time in mice

with treatment with 5% pycnogenol after induction of burn wounds was

about three days less than the control group, and the measurement of

the scar tissue was also 2.6 times less than the control group (Blazs

et al., 2004). We speculate that the discrepancy may be due to a few

reasons. First, the previous study used a higher concentration of

pycnogenol, 1%, 2% and 5%, compared to our study. Second, there

was difference in the absorption rate of pycnogenol because the

administration of pycnogenol was in conjunction with a gel substance

called Carbomer 934 P in the other studies. In our study, however,

pycnogenol was injected in the form of an aqueous solution. Methods

to induce wounds in wound recovery experiments can be largely

divided into burning, full thickness incision, and excision of some

tissues. In most other studies, the most common form of wound

- 42 -

induction was burning, unlike this current study. Grimm et al. (2006)

reported that pycnogenol promotes inflammatory responses, in that

pycnogenol interferes with matrix metalloproteinase-9 (MMP-9)

secretion by monocytes. Also, pycnogenol has been shown to inhibit the

inflammatory response of UV-induced wounds in a

concentration-dependent manner (Sime et al., 2004). When we

examined the influx of inflammatory cells, there were less

inflammatory cells in the pycnogenol-treated group than in the control

group only on day 1. From days 3 to 5, however, there were more

inflammatory cells in this group than the control group. On day 7, a

higher tendency to increase was observed in the treated group

compared to the control group. Therefore, it appears that pycnogenol

inhibits inflammatory responses in the early period of wound healing,

but as time passes, its effect wanes. However, both the degree of

contraction of wounds and the collagen deposit time were higher in the

pycnogenol-treated group than the control group on day 7. Pycnogenol

also stimulates the formation of a substrate at the second half of the

wound recovery period. Recently, one study said that an Ocimum

sanctum extract, a kind of polyphenol, increases the synthesis of

collagen, which is the main ingredient, by promoting proliferation of

fibroblasts (Shetty et al., 2007). Also, grape seed extracts, another

powerful antioxidant, was demonstrated to stimulate the crosslinking of

collagen produced in the fibroblasts (Han et al., 2003). Altogether,

pycnogenol appears to inhibit the inflammatory response during the

wound recovery process in the early stage and to promote substrate

formation of the derma.

- 43 -

Saponins are plant extracts that have extensive biological activities.

The promotion of anti-oxidants and anti-inflammatory reactions are

included among their functions (Guclu-Ustundag and Mazza, 2007).

Saponins are one of the various types of glycosides that exist in

higher orders of plants (Sparg et al., 2004). Saponin types are

classified and named based on the internal structure. In particular, a

certain saponin referred to as fruticesaponin B is known to have very

high anti-inflammatory activities (Just et al., 1998). Navarro et al.

reported that saponins may have high or low activity depending upon

their internal structure. In fact, only two types of saponins tested were

shown to reduce neutrophil entry to the wound sites, thereby

alleviating chronic skin inflammatory responses. In this study, wound

healing in the saponin-treated group progressed much faster than the

control group on day 5, and both sides of the incisional wounds were

fully joined on day 7. The wound area shrunk more in the

saponin-treated group than the control group at all time points

evaluated with the exception of day 1, and the rate of keratinocyte

migration in the saponin-treated group appeared to be higher than the

control group during all periods except day 1. Other research reported

that the burn wound area in the saponin-treated group gradually

increased up to day 4 then gradually decreased until day 20, while, in

the control group, the burn wound area gradually increased up to day

8 and then tended to diminish in size (Kimura et al., 2006). It is

assumed in this case that the long lead time in healing the burn wound

was the result of an inflammatory reaction around the burn wound,

which persisted longer (Ramzy et al., 1999). In addition, it was

- 44 -

reported that saponin increased the expression of factors relevant to

proliferation, and consequently, promoted the proliferation of epidermal

cells (Choi, 2002). Likewise, in our study, we found the rate of

keratinocyte migration involved in re-epithelialization to be faster in

the saponin-treated group than in the control group. Therefore, it is

assumed that saponin not only enhances epidermal cell proliferation but

also promotes keratinocyte migration. When the influx of inflammatory

cells was measured after wounding, the number of cells in the

saponin-treated group were obviously less and to diminish on days 1

and 3 compared to the control group, but appeared to have a tendency

to increase from day 5. Eventually, the number of inflammatory cells

appeared to be greater in the saponin-treated group than the control

group on day 7. Even in the study by Kimura et al., the number of

leukocytes and macrophages appeared to increase up to day 9 after a

burn wound, reportedly due to the expression of IL-1 by hypoxia

inducible factor-1, which induced the accumulation of macrophages.

Accordingly, we can assume that saponin is involved in the inhibition

of inflammatory responses at the early stage. Furthermore, wound

shrinkage measurements appeared to be sharply increased from day 3

on. Matrix remodeling analysis confirmed that matrix synthesis was

stimulated more in the saponin-treated group compared to the control

group. A recent study revealed that when saponin was used to treat

skin tissue exposed to ultraviolet rays, collagen synthesis of fibroblasts

was increased and the expression of matrix metalloproteinases was

inhibited (Kim et al., 2009). Furthermore, it was also revealed that

saponin increased collagen synthesis in skin fibroblasts through

- 45 -

phosphorylation of the Smad 2 protein (Lee et al., 2007). Thus, it is

assumed that saponin will promote the re-synthesis of matrix at the

site of a skin wound.

During the skin wound recovery process, pycnogenol did not promote

re-epithelialization of the wound site but inhibited the initial

inflammatory response and promoted substrate synthesis of the second

half. Also, saponin promoted re-epithelialization of the wound site and

effectively inhibited the initial inflammatory response and promoted the

substrate synthesis. Taking all results together, it appears that saponin

is more effective for wound recovery in wounds inflicted by incision.

To determine the effect of pycnogenol and saponin treatment on the

expression of inflammation-related cytokines during the wound recovery

process, protein and mRNA expression of proteases such as MMPs

expressed at the wound site can be further investigated in the future.

Also, further investigation can be conducted with different treatment

methods or concentrations of pycnogenol and saponin and other modes

of wound infliction.

- 46 -

Conclusion

To determine the effect of pycnogenol and saponin treatment on the

skin wound healing process, we induced incision wounds of dermal

depth on the back of mice and observed the difference between the

control, pycnogenol-, or saponin-treated groups. We extracted the

wound tissues on days 1, 3, 5, and 7 after inducing the wounds and

performed the analyses for the substrate re-synthesis, wound

contraction, inflammatory cells influx, keratinocyte migration rate,

wound measurements, and histology.

Conclusions based on the experimental results are as follows:

1. Pycnogenol does not promote re-epithelization of the wound site but

inhibits the initial inflammatory response and promotes substrate

synthesis of the second half.

2. Saponin promotes re-epithelization of the wound site and inhibits

the initial inflammatory response and promotes substrate synthesis.

3. Saponin is considered to be more effective than pycnogenol in the

wound recovery process.

- 47 -

REFERENCES

1. Apers S, Baronikova S, Sindambiwe JB, Witvrouw M, De Clercq E,

Vanden Berghe D, Van Marck E, Vlietinck A, Pieters L. Antiviral,

haemolytic and molluscicidal activities of triterpenoid saponins from

Maesa lanceolata: establishment of structure-activity relationships.

Planta Med 67:528-532, 2001.

2. Babior BM. Phagocytes and oxidative stress. Am J Med 109:33-44,

2000.

3. Baumann E, Stoya G, Volkner A, Richter W, Lemke C, Linss W.

Hemolysis of human erythrocytes with saponin affects the

membrane structure. Acta Histochem 102:21-35, 2000.

4. Berryman AM, Maritim AC, Sanders RA, Watkins III JB. Influence

of treatment of diabetic rats with combinations of pycnogenol,

beta-carotene, and alpha-lipoic acid on parameters of oxidative

stress. J Biochem Mol Toxicol 18:345-352, 2004.

5. Blazso G. Gabor M, Rohdewald P. Anti-inflammatory activities of

procyanidin containing extracts from Pinus pinaster Ait. after oral

and cutaneous application. Pharmazie 52(5):380-382, 1997.

6. Blazso G, Gabor M, Schonlau F, Rohdewald P. Pycnogenol

accelerates wound healing and reduces scar formation. Phytother

- 48 -

Res 18:579-581, 2004.

7. Chida M, Suzuki K, Nakanishi-Ueda T, Ueda T, Yasuhara H, Koide

R, Armstrong D. In vitro testing of antioxidants and biochemical

end-point in bovine retinal tissue. Ophthalmic Res 31:407-415,

1999.

8. Cho KJ, Yun CH, Yoon DY, Cho YS, Rimbach G, Packer L, Chung

AS. Effect of bioflavonoids extracted from the bark of Pinus

maritima on proinflammatory cytokine interleukin-1 production in

lipopolysaccharide- stimulated RAW 264.7. Toxicol Appl Pharmacol

168(1):64-71, 2000.

9. Choi S. Epidermis proliferative effect of the Panax ginseng

ginsenoside Rb2. Arch Pharm Res 25:71-76, 2002.

10. Clark RAF. Wound repair: overview and general considerations. In:

Clark RA, Henson PM. The molecular and cellular biology of wound

repair. 2nd ed. New York: Plenum Press, p.513-560, 1996.

11. Devaraj S, Vega-Lóez S, Kaul N, Schölau F, Rohdewald P, Jialal

I. Supplementation with a pine bark extract rich in polyphenols

increases plasma antioxidant capacity and alters the plasma

lipoprotein profile. Lipids 37:931-934, 2002.

12. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair:

- 49 -

molecular and cellular mechanisms. J Invest Dermatol 127:514-525,

2007.

13. Grimm T, ChovanováZ, MuchováJ, SumegováK, LiptáováA,

DurackováZ, Höger P. Inhibition of NF-kappaB activation and

MMP-9 secretion by plasma of human volunteers after ingestion of

maritime pine bark extract (Pycnogenol). J Inflamm (Lond). 27;3:1,

2006.

14. Guan DW, Ohshima T, Kondo T. Immunohistochemical study on Fas

and Fas ligand in skin wound healing. Histochem J 32:85-91, 2000.

15. Guclu-Ustundag O, Mazza G. Saponins: properties, applications and

processing. Crit Rev Food Sci Nutr 47:231-258, 2007.

16. Han B, Jaurequi J, Tang BW, Nimni ME. Proanthocyanidin: a

natural crosslinking reagent for stabilizing collagen matrices. J

Biomed Mater Res A. 65(1):118-124, 2003.

17. Hinz B. Formation and function of the myofi broblast during tissue

repair. J Invest Dermatol 127:526-537, 2007.

18. Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G.

Mechanical tension controls granulation tissue contractile activity

and myofi broblast differentiation. Am J Pathol 159:1009-1020,

2001.

- 50 -

19. Hsu S. Green tea and the skin. J Am Acad Dermatol

52:1049-1059, 2005.

20. Just MJ, Recio MC, Giner RM, Cuélar MJ, Má5ñz S, Bilia AR, Rís

JL. Anti-infl ammatory activity of unusual lupane saponins from

Bupleurum fruticescens. Planta Med 64:404-407, 1998.

21. Kang JS. Cosmetic surgery. 3rd ed. Seoul: Kunga Press, 2004.

22. Killeen GF, Madigan CA, Connolly CR, Walsh GA, Clark C, Hynes

MJ, Timmins BF, James P, Headon DR, Power RF. Antimicrobial

saponins of Yucca schidigera and the implications of their in vitro

properties for their in vivo impact. J Agric Food Chem

46:3178-3186, 1998.

23. Kim YG, Sumiyoshi M, Sakanaka M, Kimura Y. Effects of ginseng

saponins isolated from red ginseng on ultraviolet B-induced skin

aging in hairless mice. Eur J Pharmacol 602:148-156, 2009.

24. Kimura Y, Sumiyoshi M, Kawahira K, Sakanaka M. Effects of

ginseng saponins isolated from red ginseng roots on burn wound

healing in mice. Br J Pharmacol 148:860-870, 2006.

25. Konishi M, Hano Y, Takayama M, Nomura T, Hamzah AS, Ahmad

RB, Jamani H. Triterpenoid saponins from Hedyotis nudicaulis.

- 51 -

Phytochemistry 48:525-528, 1998.

26. Lee J, Jung E, Lee J, Huh S, Kim J, Park M, So J, Ham Y, Jung K,

Hyun CG et al. Panax ginseng induces human type I collagen

synthesis through activation of Smad signaling. J Ethnopharmacol

109:29-34, 2007.

27. Navarro P, Giner RM, Recio MC, Manez S, Cerda-Nicolas M, Rís

JL. In vivo anti-inflammatory activity of saponins from Bupleurum

rotundifolium. Life Sci 68:1199-1206, 2001.

28. Oda K, Matsuda H, Murakami T, Katayama S, Ohgitani T,

Yoshikawa M. Adjuvant and haemolytic activities of 47 saponins

derived from medicinal and food plants. Biol Chem 38:67-74, 2000.

29. Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic

properties of a procyanidin-rich extract from pine (Pinus maritima)

bark, pycnogenol. Free Radic Biol Med 27:704-724, 1999.

30. Ramzy PI, Barret JP, Herndon DN. Thermal injury. Crit Care Clin

15:333-352, ix, 1999.

31. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant

activity relationships of fl avonoids and phenolic acids. Free Radic

Biol Med 20:933-956, 1996.

- 52 -

32. Rohdewald P. A review of the French maritime pine bark extract

(Pycnogenol), a herbal medication with a diverse clinical

pharmacology. Int J Clin Pharmacol Ther 40(4):158-168, 2002.

33. Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S.

Oxygen, oxidants, and antioxidants in wound healing: an emerging

paradigm. Ann N Y Acad Sci 957:239-249, 2002.

34. Shetty S, Udupa S, Udupa L. Evaluation of antioxidant and wound

healing effects of alcoholic and aqueous extract of Ocimum

sanctum Linn in rats. Evid Based Complement Alternat Med.

5(1):95-101, 2007.

35. Sime S, Reeve VE. Protection from inflammation, immunosuppression

and carcinogenesis induced by UV radiation in mice

by topical Pycnogenol. Photochem Photobiol 79(2):193-198, 2004.

36. Simoes CM, Amoros M, Girre L. Mechanism of antiviral activity of

triterpenoid saponins. Phytother Res 13:323-328, 1999.

37. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med

341:738-746, 1999.

38. Sparg SG, Light ME, van Staden J. Biological activities and

distribution of plant saponins. J Ethnopharmacol 94:219-243, 2004.

- 53 -

39. Stephens P, Thomas DW. The cellular proliferative phase of the

wound repair process. J Wound Care 11:253-261, 2002.

40. Toriseva M, Kahari VM. Proteinases in cutaneous wound healing.

Cell Mol Life Sci 66:203-224, 2009.

41. Virgili F, Kobuchi H, Packer L. Procyanidins extracted from Pinus

maritima (Pycnogenol): scavengers of free radical species and

modulators of nitrogen monoxide metabolism in activated murine

RAW 264.7 macrophages. Free Radic Biol Med. 24(7-8):

1120-1129, 1998.

42. Wang ZY, Zhang J, Lu SL. Objective evaluation of burn and

post-surgical scars and the accuracy of subjective scar type

judgment. Chin Med J (Engl) 121:2517-2520, 2008.

43. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in

wound healing. J Invest Dermatol 127:998-1008, 2007.

44. Yogeeswari P, Sriram D. Betulinic acid and its derivatives: a

review on their biological properties. Curr Med Chem 12:657-666,

2005.

- 54 -

Pycnogenol°ú SaponinÀÌ ÇǺΠâ»óÄ¡À¯¿¡ ¹ÌÄ¡´Â È¿°ú

±è ¿µ ¼ö

Àü³²´ëÇб³´ëÇпø ¼öÀÇÇаú

(Áöµµ±³¼ö : ¹èÃá½Ä)

(±¹¹®ÃÊ·Ï)

ÇǺΠ»óóȸº¹Àº ¿©·¯ ÀÎÀÚµéÀÇ Á¤È®ÇÑ Á¶ÀýÇÏ¿¡ ¼­·Î ´Ù¸¥ ¼¼Æ÷µéÀÌ ¼Õ»óµÈ

Á¶Á÷À» Àç»ýÇÏ´Â °úÁ¤À» ÅëÇØ ÀϾ´Ù. ÇöÀç ÇǺΠ»óóġÀ¯¸¦ À§ÇØ »ç¿ëÇÏ´Â ÇÕ

¼º¾àÁ¦µéÀ̳ª Ç×»ýÁ¦µéÀº °ú¹Î¹ÝÀÀÀ̳ª ³»¼º±Õ ÃâÇö °°Àº ¿©·¯ ºÎÀÛ¿ëÀ» ¾ß±â½ÃÅ°

°í ÀÖ´Ù. µû¶ó¼­ ÃÖ±Ù¿¡´Â Àΰø¾àÁ¦¸¦ ´ë½ÅÇÏ¿© ½Ä¹°¿¡¼­ ÃßÃâÇÑ Ãµ¿¬¹°µéÀÇ »óó

Ä¡À¯ È¿°ú¿¡ ´ëÇÑ ¿¬±¸°¡ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ´Ù. PycnogenolÀº ¼Ò³ª¹« ²®Áú¿¡¼­

ÃßÃâÇÑ Æú¸®Æä³î È­ÇÕ¹°·Î¼­ Ç×»êÈ­Á¦ ±â´É»Ó¸¸ ¾Æ´Ï¶ó ¿°Áõ¼º Áúȯ¿¡µµ È¿°ú°¡

ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ³´Ù. ¶ÇÇÑ saponinÀº ¸Å¿ì ³ôÀº Ç׿°Áõ¹ÝÀÀ È°¼ºÀ» °¡Áö°í ÀÖ´Â

°ÍÀ¸·Î ¹àÇôÁ³´Ù. º» ¿¬±¸¿¡¼­´Â pycnogenol°ú saponinÀÇ ¾Ë·ÁÁø ±â´ÉÀ» ¹ÙÅÁÀ¸

·Î ÇǺΠ»óóȸº¹°úÁ¤¿¡¼­ ±× È¿°ú¸¦ Á¶Á÷ÇÐÀûÀ¸·Î ¹àÈ÷°íÀÚ ÇÏ¿´´Ù.

µ¿ÀÏ Á¶°Ç¿¡¼­ ÀÏÁ¤±â°£ »çÀ°ÇÑ 48¸¶¸® »ýÁãÀÇ µîÂÊ ÇǺο¡ ±æÀÌ 1cm, ÁøÇÇ

Ãþ ±íÀ̱îÁö ¿Ü°úÀû »óó¸¦ À¯¹ß½ÃŲ ÈÄ ´ëÁ¶±º, pycnogenol ¶Ç´Â saponinÀ»

ó¸®ÇÑ ½ÇÇ豺À¸·Î ³ª´©¾î 1ÀÏ, 3ÀÏ, 5ÀÏ, 7ÀÏ ÈÄ¿¡ °¢°¢ »óó ºÎÀ§ Á¶Á÷À» ÀûÃâ

ÇÏ¿´´Ù. ÀûÃâÇÑ Á¶Á÷Àº Á¶Á÷ Ç¥º» Á¦ÀÛ°úÁ¤À» °ÅÄ£ ÈÄ »óóºÎÀ§ÀÇ ¸éÀû, °¢Áú¼¼

Æ÷ À̵¿À², À¯ÀÔµÈ ¿°Áõ¼¼Æ÷¼ö, »óó ¼öÃàÁ¤µµ ±×¸®°í ±³¿øÁú ħÀÛ°ú °°Àº Á¶Á÷

°èÃøÇÐÀû ºÐ¼®À» ½Ç½ÃÇÏ¿´´Ù.

½ÇÇè°á°ú pycnogenol 󸮱ºÀº ´ëÁ¶±º¿¡ ºñÇØ ¸ðµç ±â°£¿¡ °ÉÃÄ »óó¸éÀûÀÌ ´õ

³Ð¾ú°í °¢Áú¼¼Æ÷ À̵¿ Á¤µµ´Â 1ÀÏ°¸¦ Á¦¿ÜÇÏ°í ¸ðµÎ ´ëÁ¶±ºº¸´Ù ³·°Ô ³ªÅ¸³µ´Ù.

¶ÇÇÑ »óóºÎÀ§ÀÇ ¿°Áõ¼¼Æ÷ ¼ö¸¦ ºÐ¼®ÇÑ °á°ú pycnogenol 󸮱ºÀº ´ëÁ¶±º¿¡ ºñÇØ

- 55 -

1ÀÏ°¸¸ Á¦¿ÜÇÏ°í ¸ðµç ±â°£¿¡ °ÉÃÄ ¿°Áõ¼¼Æ÷ ¼ö°¡ ´õ ³ô¾Ò´Ù. »óó ¼öÃ൵ ºÐ¼®

¿¡¼­´Â pycnogenol 󸮱ºÀº 1ÀϺÎÅÍ 5ÀÏ°±îÁö ¼öÃàÁ¤µµ°¡ ´ëÁ¶±ºº¸´Ù ³·¾ÒÁö¸¸

7ÀÏ°¿¡´Â ´õ ³ô°Ô ³ªÅ¸³µ´Ù. ±³¿øÁú ħÀÛ ºÐ¼®°á°ú pycnogenol 󸮱ºÀº ´ëÁ¶±º

¿¡ ºñÇؼ­ 7ÀÏ°¿¡ ´õ ³ô°Ô ³ªÅ¸³µ´Ù. Saponin 󸮱ºÀÇ »óó¸éÀûÀº 1ÀÏ°¸¦ Á¦

¿ÜÇÑ 3ÀÏ¿¡¼­ 7ÀϱîÁö ´ëÁ¶±ºº¸´Ù ´õ Á¼°Ô ÃøÁ¤µÆ°í °¢Áú¼¼Æ÷ À̵¿À²Àº ´ëÁ¶±º¿¡

ºñÇØ ³ô°Ô ³ªÅ¸³µ´Ù. »óóºÎÀ§ÀÇ ¿°Áõ¼¼Æ÷¼ö´Â saponin 󸮱ºÀÇ ´ëÁ¶±º¿¡ ºñÇØ 1

ÀÏ°¿Í 3ÀÏ°¿¡ ÇöÀúÈ÷ Àû°Ô ³ªÅ¸³µ°í ÁÙ¾îµå´Â °æÇâÀ» º¸¿´´Ù. »óó ¼öÃ൵´Â

saponin 󸮱ºÀÌ ´ëÁ¶±ºº¸´Ù ´õ ³ôÀº ¼öÄ¡¸¦ ³ªÅ¸³Â´Ù. ¶ÇÇÑ ±³¿øÁú ħÀÛÀº

saponin 󸮱ºÀÌ ´ëÁ¶±º¿¡ ºñÇØ ´õ ÃËÁøµÇ´Â °ÍÀ¸·Î °üÂûµÇ¾ú´Ù.

ÀÌ»óÀÇ °á°úµéÀ» Á¾ÇÕÇØ º¸¸é pycnogenolÀº »óóºÎÀ§ÀÇ Àç»óÇÇÈ­¸¦ ÃËÁø½ÃÅ°

Áö ¾Ê¾ÒÁö¸¸ Ãʱ⠿°Áõ¹ÝÀÀÀ» ¾ïÁ¦ÇÏ°í ÈĹݺÎÀÇ ±âÁúÇÕ¼ºÀ» Áõ°¡½ÃÅ°´Â °ÍÀ¸·Î

È®ÀεǾú´Ù. ¹Ý¸é saponinÀº Àç»óÇÇÈ­¸¦ ÃËÁø½ÃÄ×À¸¸ç ¿°Áõ¹ÝÀÀÀ» ¾ïÁ¦ÇÏ¿´°í

±âÁú ÀçÇÕ¼ºÀ» À§ÇÑ ±³¿øÁú ħÀÛÀ» ÃËÁøÇÏ¿´´Ù. µû¶ó¼­ ÇǺΠ»óóȸº¹°úÁ¤¿¡¼­´Â

pycnogenol º¸´Ù saponinÀÌ Àü¹ÝÀûÀ¸·Î È¿°úÀûÀÎ °ÍÀ¸·Î »ý°¢µÈ´Ù.

÷ºÎÆÄÀÏ
pycnogenol°úsaponinÀÌ_ÇǺÎâ»óÄ¡À¯¿¡¹ÌÄ¡´ÂÈ¿°ú.pd.pdf